Recognizing Outstanding Contributions to the Canadian Cancer Research Community

The CCRA Awards, initiated in 2011, recognize and celebrate the outstanding contributions of individuals who have had a remarkable impact on cancer research and the cancer research community.

On November 8, 2021, the CCRA recognized five outstanding leaders in the Canadian cancer research community at their 2021 Canadian Cancer Research Conference. We invited the award recipients to share some remarks below.

2021 CCRA Award Recipients

  • Mr. Barry Stein, President & CEO Colorectal Cancer Canada is the recipient of the CCRA Award for Exceptional Leadership in Patient Involvement in Cancer Research for his tireless advocacy to improve treatment access for cancer patients by facilitating the engagement of patients in clinical trials and for his commitment to promoting primary prevention and ensuring population-based colorectal cancer screening for all people in Canada.
  • Dr. Linda Watson, Scientific Director of Applied Research and Patient Experience, Cancer Care Alberta is the recipient of the CCRA Award for Exceptional Leadership in Patient Involvement in Cancer Research for her dedication to person-centred care and commitment to improving the patient experience for cancer patients in Alberta and across Canada and for her leadership in promoting oncology nursing and improving patient outcomes through implementation science.
  • Dr. Bradly Wouters, Senior Scientist, Princess Margaret Cancer Centre; Executive VP Science and Research, University Health Network is the recipient of the CCRA Award for Exceptional Leadership in Cancer Research for his commitment to facilitating research excellence across the cancer research spectrum in his leadership role at the University Health Network, for promoting multi-centred research collaborations to accelerate translational research, and for his responsiveness to the national and global needs created by the pandemic.
  • Dr. Connie Eaves, PhD, FRSC, FRSE, FRSL, Terry Fox Laboratory, BC Cancer and Department of Medical Genetics and School of Biomedical Engineering, University of British Columbia is the recipient of the CCRA Award Outstanding Achievements in Cancer Research for her pioneering, cutting-edge, and paradigm-shifting scientific contributions to the study of hematopoietic, mammary and cancer stem cells and for her dedication to outstanding mentorship of trainees, early-career investigators, and promotion of women in science.
  • Ms. Elisabeth Baugh, Chair of World Ovarian Cancer Coalition and past CEO of Ovarian Cancer Canada is the recipient of CCRA Award for Distinguished Service to Cancer Research for her leadership as CEO of Ovarian Cancer Canada. She created a unified national organization to support women in Canada who are living with ovarian cancer, generated a strategic vision of research priorities, and mobilized women with ovarian cancer to successfully advocate for a first-ever targeted federal investment in ovarian cancer research. Elisabeth also championed ovarian cancer on the world stage, founding World Ovarian Cancer Day in 2013, and leading a global coalition calling for the urgent prioritization of this disease because all women deserve the best care.

Congratulations to these individuals who have had a remarkable impact on cancer research and the cancer research community as well as those who have shown exceptional leadership in patient involvement in cancer research.

Award Categories

The following CCRA Awards were presented in 2021:

Exceptional Leadership in Cancer Research

Awarded to an individual who has made exceptional contributions to fostering the development of cancer research in Canada through their leadership in organizations, or development of collaborative research opportunities or initiatives that have had a transformative impact.

Outstanding Achievements in Cancer Research

Awarded to a cancer researcher from any research discipline for outstanding lifetime achievements which have had an impact in greatly advancing our understanding of cancer, the treatment of cancer, and/or cancer control in Canada.

Distinguished Service to Cancer Research

Awarded to an individual whose work has had a substantial impact on public education, policy, or discourse on cancer control, cancer research, and/or science literacy in Canada.

Exceptional Leadership in Patient Involvement in Cancer Research

Awarded to an individual who has made exceptional contributions to fostering patient involvement in cancer research in Canada. The inaugural award was presented at CCRC 2017 in Vancouver.

In 2021, winners will receive a framed certificate and cash award.

Nominations Review Process

A subcommittee of the 2021 Canadian Cancer Research Conference’s Executive Planning Committee and CCRA Board reviewed nominations and recommended the award recipients in each category for approval by the full CCRA Board. Decisions were made in summer 2021 and the awards are presented in November at the CCRC 2021 Virtual Event.

Nominees are adjudicated on 5-point scales for three criteria (maximum score of 15): alignment with the award category, achievements, and impact. The CCRA Executive Office may communicate with the nominator if it is felt that the nominee is more appropriate for another award category. In recognition of systemic barriers and inequities, the Nomination Committee reserves the right to add 3 points to the scores of nominees who are from groups traditionally under-represented in cancer leadership positions.

Should you have any questions or wish to receive further information about the CCRA awards (including the nomination and adjudication processes), please contact us at ccra.team@partnershipagainstcancer.ca.

 

Learn more about previous CCRA Awards recipients: